Terryville, CT, United States of America

Michael Paul Levandoski

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Henkel Ag & Company, Kgaa. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Paul Levandoski: Innovator in Curable Compositions

Introduction

Michael Paul Levandoski is an accomplished inventor based in Terryville, CT (US). He has made significant contributions to the field of curable compositions, particularly focusing on reaction-induced phase separation. His innovative work has led to advancements in materials with improved physical and chemical properties.

Latest Patents

Levandoski holds a patent for "Curable compositions for production of reaction induced phase separated compositions with improved properties." This patent describes curable compositions that undergo reaction-induced phase separation of domains in a cured matrix. These compositions respond to specific curing conditions, enhancing their physical properties, such as glass transition temperature and thermal degradation.

Career Highlights

Levandoski is associated with Henkel Ag & Company, Kgaa, where he applies his expertise in developing advanced materials. His work has been instrumental in creating compositions that offer beneficial properties for various applications.

Collaborations

Throughout his career, Levandoski has collaborated with notable colleagues, including Bahram Issari and Christina Despotopoulou. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

Michael Paul Levandoski's contributions to the field of curable compositions demonstrate his commitment to innovation and excellence. His work continues to impact the industry positively, paving the way for future advancements in material science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…